{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-02-01T12:28:14.990217+00:00",
  "news": [
    {
      "title": "Atle Fund Management AB Reduces Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNY3RhZEhHLTg3RkZUVWdEQVBEQ3h3dnB1T1NscWY1V1FVOXhZa2VCVVF3U0ZfQThPME9haGZMSDZqQkJkaEwtOFJ6ekN0dTJ0XzUtaEx3dmg2TWNXcFlEWElDZUxCR1JZYU95ZWM2WHRJbUVEcmxqbE5MbFZVQTQ1TUFmSURDTjFaRkpmMFFLZWpBTG1qbzM2WnJhd0JwR1Z0b3YtR2NPWEhmLVVWRjhNWkNwYUhndnhGdTAtOUlVX1ZUdDlQS2E4N3VwWGIzUjEyWHFCVVdUM0VzcXV5NFE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNY3RhZEhHLTg3RkZUVWdEQVBEQ3h3dnB1T1NscWY1V1FVOXhZa2VCVVF3U0ZfQThPME9haGZMSDZqQkJkaEwtOFJ6ekN0dTJ0XzUtaEx3dmg2TWNXcFlEWElDZUxCR1JZYU95ZWM2WHRJbUVEcmxqbE5MbFZVQTQ1TUFmSURDTjFaRkpmMFFLZWpBTG1qbzM2WnJhd0JwR1Z0b3YtR2NPWEhmLVVWRjhNWkNwYUhndnhGdTAtOUlVX1ZUdDlQS2E4N3VwWGIzUjEyWHFCVVdUM0VzcXV5NFE?oc=5\" target=\"_blank\">Atle Fund Management AB Reduces Position in Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-02-01T10:08:15+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Vertex Pain Setback Prompts Fund Exit And Recheck Of Valuation Gap - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQNi03VFpONTdrRGMxN2VnS0tzUUlpVjFnamM3MFBvcFlfWmZhNzJFSm02MFNoRmJlMjdPUW52NTdjSzRJNnk3TFVjVk92a1E1ZUdZZFZyQzJkOE1mVUpIenR1UG9Rc0tYWjRQbkpiRjc4NWpwdk1CbHpJeTFnN3VfSjhxNEI?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxQNi03VFpONTdrRGMxN2VnS0tzUUlpVjFnamM3MFBvcFlfWmZhNzJFSm02MFNoRmJlMjdPUW52NTdjSzRJNnk3TFVjVk92a1E1ZUdZZFZyQzJkOE1mVUpIenR1UG9Rc0tYWjRQbkpiRjc4NWpwdk1CbHpJeTFnN3VfSjhxNEI?oc=5\" target=\"_blank\">Vertex Pain Setback Prompts Fund Exit And Recheck Of Valuation Gap</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-02-01T06:08:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPZG5FX0otdUtWQXFNcVJHS2FaUnRjNFNmbHB6NURFN1pBdUxlZllFMmFaeE93U3FUSF9kT0RxS0ZWMzFrMnFmUnVvNS1XX2VRVjEwTHpYUUNidXVYZjktZ2RrRlhRWUpQTUgyWklsV1BIemJNNkh6dlBsdC0yYUluRDBBeFdIX1RtNjBOS1Vhb3RwU3JRWEJ4MA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPZG5FX0otdUtWQXFNcVJHS2FaUnRjNFNmbHB6NURFN1pBdUxlZllFMmFaeE93U3FUSF9kT0RxS0ZWMzFrMnFmUnVvNS1XX2VRVjEwTHpYUUNidXVYZjktZ2RrRlhRWUpQTUgyWklsV1BIemJNNkh6dlBsdC0yYUluRDBBeFdIX1RtNjBOS1Vhb3RwU3JRWEJ4MA?oc=5\" target=\"_blank\">Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2026-01-29T14:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Why Analysts Are Positive on Vertex Pharmaceuticals Incorporated (VRTX)’s Story - Insider Monkey",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Why Analysts Are Positive on Vertex Pharmaceuticals Incorporated (VRTX)’s Story</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Insider Monkey</font>",
      "published": "2026-01-31T17:38:15+00:00",
      "source": "Insider Monkey"
    },
    {
      "title": "Is Vertex Pharmaceuticals (VRTX) Pricing Reflect Its DCF Discount And Premium P/E Ratio - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxOQzdfVVl0bGJJcUE0MjNJUkUzVGVmRlFvT2tmeHZZT0JsVkwxQVozV3BsUGkwNlM3aG5VcFByT0c2d2FYM3ltdXJYZnRQTVl2NGJ4SEJ6WHQ1T0h3NE5FWTN5TDRsYmhwUGhkR0MxZUVkYklhaGJQazJ2MFFZSWlPZURiQjR2R1o3Z3BtdTMwcl9XdXFHVFdmMUN6WXl4STJ4TEYyS3FVSk1Tc09zbWU0ZU9lVnhfOXJrYWR2RUkzSEJPX2Y5T2FXbVlnNEpua0F5WjRVM0ptZ1J5ZzFUNzBXUmNQV2wtTzVfYWdkUA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOQzdfVVl0bGJJcUE0MjNJUkUzVGVmRlFvT2tmeHZZT0JsVkwxQVozV3BsUGkwNlM3aG5VcFByT0c2d2FYM3ltdXJYZnRQTVl2NGJ4SEJ6WHQ1T0h3NE5FWTN5TDRsYmhwUGhkR0MxZUVkYklhaGJQazJ2MFFZSWlPZURiQjR2R1o3Z3BtdTMwcl9XdXFHVFdmMUN6WXl4STJ4TEYyS3FVSk1Tc09zbWU0ZU9lVnhfOXJrYWR2RUkzSEJPX2Y5T2FXbVlnNEpua0F5WjRVM0ptZ1J5ZzFUNzBXUmNQV2wtTzVfYWdkUA?oc=5\" target=\"_blank\">Is Vertex Pharmaceuticals (VRTX) Pricing Reflect Its DCF Discount And Premium P/E Ratio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-30T22:49:10+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Barclays Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPbUtGZ1F5RnNPTi1abjV4SkVZMGZGMzFBTS0yTVFseVh1WmNBV3VNTkVTZHJXN29ZMlMyZUkxd1Fvdk82Ry0yQ2s3WGZiUXFzTWo0eEd1cHdjOWNQbXRVZzA2R2k4YWxhWGpMcUNZY29BV292QUlMQUc3dnVtdUllNHVDQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPbUtGZ1F5RnNPTi1abjV4SkVZMGZGMzFBTS0yTVFseVh1WmNBV3VNTkVTZHJXN29ZMlMyZUkxd1Fvdk82Ry0yQ2s3WGZiUXFzTWo0eEd1cHdjOWNQbXRVZzA2R2k4YWxhWGpMcUNZY29BV292QUlMQUc3dnVtdUllNHVDQQ?oc=5\" target=\"_blank\">Barclays Upgrades Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-01-29T00:03:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Responsibility | Grants and Giving - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPempkZnJfemR2dHhGT3ZsRkJ0UDdUZ0pUUURUczhJS0I3N1JMVS04YmpRNGF0UXA2dmxFVF9seXZXRlFBUW5ZUmNZX0pGNHQ4VGFIMFFvSFhNX3VaUHA1Rm44T2pLbUctMDV6LWdXeHlzaWV4cHRIXzlvSjVwM3VkaVdxTnZKemluVC1KZUhrUHQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxPempkZnJfemR2dHhGT3ZsRkJ0UDdUZ0pUUURUczhJS0I3N1JMVS04YmpRNGF0UXA2dmxFVF9seXZXRlFBUW5ZUmNZX0pGNHQ4VGFIMFFvSFhNX3VaUHA1Rm44T2pLbUctMDV6LWdXeHlzaWV4cHRIXzlvSjVwM3VkaVdxTnZKemluVC1KZUhrUHQ?oc=5\" target=\"_blank\">Responsibility | Grants and Giving</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2026-01-21T19:40:49+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Value Case - Chartmill",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQTG5tNFFvWTdNUmFoNVg5ZkMza0FBbE1WcjBscmlhbEtZM1RQQWZPU3JjU1M3N1ZKWTFnNURFaVQ2bmtGU19kWjNQLUlndUxqWmdiWXExd2I0Wm1tZkdhRlpwVGR5dWtSNXlsZFpUbW4yLWVFT2tLYWRpS1hxM08tS2tDX0ZSckg3Ti0wYXpfeFJsLUk2bVJqYWtZVWM1a0JCa3hDbGVwR3Nabk10ajFEZThYS3RCcGhZWnFCUkVaOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxQTG5tNFFvWTdNUmFoNVg5ZkMza0FBbE1WcjBscmlhbEtZM1RQQWZPU3JjU1M3N1ZKWTFnNURFaVQ2bmtGU19kWjNQLUlndUxqWmdiWXExd2I0Wm1tZkdhRlpwVGR5dWtSNXlsZFpUbW4yLWVFT2tLYWRpS1hxM08tS2tDX0ZSckg3Ti0wYXpfeFJsLUk2bVJqYWtZVWM1a0JCa3hDbGVwR3Nabk10ajFEZThYS3RCcGhZWnFCUkVaOA?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Value Case</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Chartmill</font>",
      "published": "2026-01-29T12:51:46+00:00",
      "source": "Chartmill"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-01-30",
      "close": 469.8999938964844
    },
    "history": [
      {
        "date": "2026-01-22",
        "close": 467.3500061035156
      },
      {
        "date": "2026-01-23",
        "close": 468.4100036621094
      },
      {
        "date": "2026-01-26",
        "close": 476.8399963378906
      },
      {
        "date": "2026-01-27",
        "close": 474.1700134277344
      },
      {
        "date": "2026-01-28",
        "close": 477.9100036621094
      },
      {
        "date": "2026-01-29",
        "close": 475.67999267578125
      },
      {
        "date": "2026-01-30",
        "close": 469.8999938964844
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}